Sökresultat - Javier Pinilla‐Ibarz

Förfina resultatet
  1. 1
    Signaling Networks Associated with BCR–ABL–Dependent Transformation

    Signaling Networks Associated with BCR–ABL–Dependent Transformation av Lori Hazlehurst, Nadine N. Bewry, Rajesh R. Nair, Javier Pinilla‐Ibarz

    Publicerad 2009
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  2. 2
    Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies

    Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies av Jessica M. McDaniel, Javier Pinilla‐Ibarz, Pearlie K. Epling‐Burnette

    Publicerad 2012
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia

    Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia av Wael Gamal, Melanie Mediavilla-Varela, Vishaal Kunta, Eva Sahakian, Javier Pinilla‐Ibarz

    Publicerad 2025
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  4. 4
    Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance

    Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance av Nadine N. Bewry, Rajesh R. Nair, Michael F. Emmons, David Boulware, Javier Pinilla‐Ibarz, Lori A. Hazlehurst

    Publicerad 2008
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management

    Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management av Jorge E. Cortés, Carlos A. Jiménez, Michael J. Mauro, Alex Geyer, Javier Pinilla‐Ibarz, Benjamin D. Smith

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  6. 6
    <scp>WT</scp>1 vaccination in <scp>AML</scp> and <scp>MDS</scp>: A pilot trial with synthetic analog peptides

    <scp>WT</scp>1 vaccination in <scp>AML</scp> and <scp>MDS</scp>: A pilot trial with synthetic analog peptides av Jason Brayer, Jeffrey E. Lancet, John J. Powers, Alan F. List, Lodovico Balducci, Rami S. Komrokji, Javier Pinilla‐Ibarz

    Publicerad 2015
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia

    Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia av Onyee Chan, Chetasi Talati, Leidy Isenalumhe, Samantha Shams, Lisa Nodzon, Michael G. Fradley, Kendra Sweet, Javier Pinilla‐Ibarz

    Publicerad 2020
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

    A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia av Kathleen N. S. Cathcart, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Joseph E. Schwartz, Victoriya Zakhaleva, Esperanza B. Papadopoulos, David A. Scheinberg

    Publicerad 2003
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells

    Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells av Rena J. May, Tao Dao, Javier Pinilla‐Ibarz, Tatyana Korontsvit, Victoriya Zakhaleva, Rong H. Zhang, P. Maslak, David A. Scheinberg

    Publicerad 2007
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Phase 1 study of INNO‐406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome‐positive leukemias after imatinib resistance or intolerance

    Phase 1 study of INNO‐406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome‐positive leukemias after imatinib resistance or intolerance av Hagop M. Kantarjian, Phillipp le Coutre, Jorge E. Cortés, Javier Pinilla‐Ibarz, Arnon Nagler, Andreas Hochhaus, Shinya Kimura, Oliver G. Ottmann

    Publicerad 2010
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease

    A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease av Kendra Sweet, Lori Hazlehurst, Eva Sahakian, John J. Powers, Lisa Nodzon, Fadi Kayali, Kelly A. Hyland, Ashley Nelson, Javier Pinilla‐Ibarz

    Publicerad 2018
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Preliminary Results of Voice (Virtual Opinions poll Independent Centered on CLL patients’ Experience): A Global Survey to Assess the Disease-Specific Knowledge and Perspectives of Real-World Patients with CLL

    Preliminary Results of Voice (Virtual Opinions poll Independent Centered on CLL patients’ Experience): A Global Survey to Assess the Disease-Specific Knowledge and Perspectives of... av Constantine S. Tam, Javier Pinilla Ibarz, Volkan Karakuş, Catherine Moura, Miguel Arturo Pavlovsky, Fernando Nicolás Piotrowsky, Martin Šimkovič, Andrew Smith, Stephan Stilgenbauer

    Publicerad 2022
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  13. 13
    Inhibition of ER stress–associated IRE-1/XBP-1 pathway reduces leukemic cell survival

    Inhibition of ER stress–associated IRE-1/XBP-1 pathway reduces leukemic cell survival av Chih-Hang Anthony Tang, Sujeewa Ranatunga, Crystina L. Kriss, Christopher L. Cubitt, Jianguo Tao, Javier Pinilla‐Ibarz, Juan R. Del Valle, Chih‐Chi Andrew Hu

    Publicerad 2014
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    NCCN Task Force Report: Tyrosine Kinase Inhibitor Therapy Selection in the Management of Patients With Chronic Myelogenous Leukemia

    NCCN Task Force Report: Tyrosine Kinase Inhibitor Therapy Selection in the Management of Patients With Chronic Myelogenous Leukemia av Susan O’Brien, Ellin Berman, Joseph O. Moore, Javier Pinilla‐Ibarz, Jerald P. Radich, Paul J. Shami, Benjamin D. Smith, David S. Snyder, Hema Sundar, Moshe Talpaz, Meir Wetzler

    Publicerad 2011
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance

    The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance av Alejandro Villagra, Fengdong Cheng, Hongwei Wang, Ildelfonso Suarez, Michelle Glozak, Michelle Maurin, Danny Nguyen, Kenneth L. Wright, Peter Atadja, Kapil N. Bhalla, Javier Pinilla‐Ibarz, Edward Seto, Eduardo M. Sotomayor

    Publicerad 2008
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  16. 16
    Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison

    Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison av Kristin M. Phillips, Javier Pinilla‐Ibarz, Eduardo M. Sotomayor, Morgan Lee, Heather Jim, Brent J. Small, Lubomir Sokol, Jeffrey E. Lancet, Sara Tinsley, Kendra Sweet, Rami S. Komrokji, Paul B. Jacobsen

    Publicerad 2012
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes

    Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes av Asmita Mishra, Maria Corrales‐Yepez, Najla Al Ali, Mohamed A. Kharfan‐Dabaja, Eric Padron, Ling Zhang, Pearlie K. Epling‐Burnette, Javier Pinilla‐Ibarz, Jeffrey E. Lancet, Alan F. List, Rami S. Komrokji

    Publicerad 2013
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    PB1945: PATIENT PERSPECTIVES ON CLL TREATMENT SIDE EFFECTS: A SUB-ANALYSIS OF THE VOICE SURVEY

    PB1945: PATIENT PERSPECTIVES ON CLL TREATMENT SIDE EFFECTS: A SUB-ANALYSIS OF THE VOICE SURVEY av Constantine S. Tam, Javier Pinilla‐Ibarz, Volkan Karakuş, Miguel Arturo Pavlovsky, Stephan Stilgebauer, Martin Šimkovič, Ana Cristina Fenili, Miguel Augusto Miroli, Carolina García-Castillo, Kathryn Huntley, Catherine Moura, Fernando Piotrowski, Mervat Mattar

    Publicerad 2023
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL

    Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL av Constantine S. Tam, Javier Pinilla‐Ibarz, Carolina García-Castillo, Ana Cristina Fenili, Kathryn Huntley, Volkan Karakuş, Mervat Mattar, Miguel Augusto Miroli, Catherine Moura, Miguel Arturo Pavlovsky, Fernando Piotrowski, Martin Šimkovič, Stephan Stilgenbauer

    Publicerad 2023
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  20. 20
    Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinib

    Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinib av Jorge E. Cortés, Andreas Hochhaus, Philipp D. le Coutre, Gianantonio Rosti, Javier Pinilla‐Ibarz, Elias Jabbour, Kathryn Gillis, Richard C. Woodman, Rick E. Blakesley, Francis J. Giles, Hagop M. Kantarjian, Michele Baccarani

    Publicerad 2011
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: